Found 109 matching trials
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies PHASE1 The primary purpose of this study is to determine the safety and efficacy o...
Show More Location
The Affiliated People's Hospital of Ningbo University
Learn More & Join Trial
A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas PHASE1 This is a clinical trial to evaluate the feasibility and safety of giving t...
Show More Status
Active Not Recruiting
Location
Weill Cornell Medicine/NewYork-Presbyterian Hospital
Learn More & Join Trial
Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia(R/R-ALL) PHASE2 The purpose of this study is to evaluate the safety and efficacy of IFN-α c...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity PHASE2 This research study is studying the combination of anakinra and axicabtagen...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases PHASE1 The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Show More Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Learn More & Join Trial
A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm PHASE2 This study is designed to evaluate the safety, efficacy, cellular kinetics,...
Show More Location
Multiple Locations
Learn More & Join Trial
TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL PHASE1 ATHENA chimeric antigen receptor (CAR)-T, a CD19-directed CAR-T cell immuno...
Show More Location
Biotherapeutic Department, Chinese PLA General Hospital
Learn More & Join Trial
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases PHASE1 This is an open, single-arm, clinical study to evaluate the efficacy and sa...
Show More Location
District One Hospital
Learn More & Join Trial
CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa) PHASE1 Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis PHASE1 The goal of this clinical trial is to characterize to understand the effect...
Show More Location
Stanford University
Learn More & Join Trial